CEP
SGMO

Chicago Equity Partners’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Chicago Equity Partners’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-12,345
Closed -$175K – 872
2018
Q2 		$175K Hold
12,345
– – 0.01% 798
2018
Q1 		$235K Buy
12,345
+610
+5% +$13K 0.01% 712
2017
Q4 		$192K Buy
+11,735
New +$175K 0.01% 716

Other funds holding SGMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Chicago Equity Partners's SGMO Position: Q3 2018 in Review

Chicago Equity Partners sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q3 2018, closing a stake of 12,345 shares — an estimated $175K sold.

Chicago Equity Partners first reported a position in SGMO in Q4 2017 and held it in 3 quarters. The position peaked at $235K in Q1 2018. 217 funds tracked by Wall St. Rank hold SGMO as of Q3 2018.

  • Chicago Equity Partners reported no remaining SANGAMO THERAPEUTICS INC position as of Q3 2018 after selling out during the quarter.
  • Chicago Equity Partners sold 12,345 SANGAMO THERAPEUTICS INC shares in Q3 2018, an estimated $175K.
  • Chicago Equity Partners first reported a position in SANGAMO THERAPEUTICS INC in Q4 2017 and held it in 3 quarters.
  • Chicago Equity Partners's SANGAMO THERAPEUTICS INC position peaked at $235K in Q1 2018.
  • 217 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q3 2018.

Based on Chicago Equity Partners's 13F filing for Q3 2018, filed 1 Nov 2018.